The Arab Drug Company Balance Sheet

Financials in millions EGP. Fiscal year is July - June.

Millions EGP. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	89.15	79.28	232.72	50.48	40.28	46.43
Short-Term Investments	-	-	-	-	-	13.88
Cash & Short-Term Investments	89.15	79.28	232.72	50.48	40.28	60.31
Cash Growth	-12.22%	-65.93%	361.00%	25.33%	-33.21%	-17.65%
Accounts Receivable	163.28	130.06	71.44	69.72	54.02	33.56
Other Receivables	21.35	76.36	48.45	20.11	28.91	15.54
Receivables	297.87	287.39	203.53	173.07	153.86	142.07
Inventory	333.33	327.72	236.28	254.09	224.85	171.7
Prepaid Expenses	-	-	0.01	-	0.11	0.1
Other Current Assets	32.71	0.74	0.34	0.41	0.43	0.93
Total Current Assets	753.05	695.12	672.88	478.05	419.53	375.11
Property, Plant & Equipment	672.99	616.53	444.4	193.36	145.5	59.19
Long-Term Investments	2.26	2.26	2.26	2.26	2.26	3.24
Long-Term Deferred Tax Assets	4.6	8.98	14.06	8.39	6.7	8.73
Other Long-Term Assets	0	-	-0	-	-0	-
Total Assets	1,433	1,323	1,134	682.07	573.98	446.27
Accounts Payable	91.37	64.52	45.63	44.18	25.26	20.45
Accrued Expenses	12	9.48	11.63	11.14	9.02	10.07
Short-Term Debt	226.26	174.41	116.7	85.26	98.66	21.21
Current Portion of Long-Term Debt	91.87	91.44	73.37	-	-	-
Current Income Taxes Payable	35.58	48.72	24.42	6.33	2.41	24.76
Other Current Liabilities	116.59	68.26	76.3	45.11	46.01	60.15
Total Current Liabilities	573.67	456.83	348.04	192.03	181.36	136.63
Long-Term Debt	233.17	245.35	324.88	103.71	52.41	-
Long-Term Leases	-	0.96	2.15	3.1	-	-
Other Long-Term Liabilities	-	-	-	0	-	-
Total Liabilities	806.84	703.15	675.06	298.84	233.78	136.63
Common Stock	120	120	60	60	60	60
Retained Earnings	484.77	478.45	377.23	301.94	258.91	227.36
Comprehensive Income & Other	21.3	21.3	21.3	21.3	21.3	22.27
Shareholders' Equity	626.07	619.74	458.53	383.23	340.21	309.63
Total Liabilities & Equity	1,433	1,323	1,134	682.07	573.98	446.27
Total Debt	551.3	512.16	517.09	192.07	151.07	21.21
Net Cash (Debt)	-462.15	-432.88	-284.38	-141.59	-110.8	39.1
Net Cash Growth	-	-	-	-	-	-33.99%
Net Cash Per Share	-38.51	-36.07	-23.70	-11.80	-8.18	2.82
Filing Date Shares Outstanding	12	12	12	12	12	12
Total Common Shares Outstanding	12	12	12	12	12	12
Working Capital	179.39	238.29	324.84	286.03	238.17	238.48
Book Value Per Share	52.17	51.65	38.21	31.94	28.35	25.80
Tangible Book Value	626.07	619.74	458.53	383.23	340.21	309.63
Tangible Book Value Per Share	52.17	51.65	38.21	31.94	28.35	25.80
Land	0.36	0.36	0.36	0.36	0.36	0.36
Buildings	272.59	272.24	82.98	61.47	61.44	49.42
Machinery	213.32	208.66	145.17	124.79	124.52	118.84
Construction In Progress	388.96	318.45	372.62	154.6	101.16	25.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.